A transplant using the patient's own stem cells (an autologous stem cell transplant) or CAR T-cell therapy are treatment options for patients with certain types of lymphoma.
CAR T cell Therapy
You are here
CAR T-cell therapy is a new treatment option for patients with multiple myeloma. Learn about the CAR T-cell products available, their effectiveness and potential side effects.
CAR T-cell therapy is a new form of treatment for patients diagnosed with acute lymphoblastic leukemia that has shown promising results. Learn who is a candidate for CAR T-cell therapy, the steps involved and potential side effects and outcomes/
Learn how CAR T-cell therapy can help patients with an aggressive lymphoma that is not cured by standard chemotherapy.
La terapia de células CAR T es un nuevo enfoque para tratar ciertos tipos de linfoma, mieloma múltiple y leucemia linfoblástica aguda que no han respondido a dos tipos de tratamiento anteriores
Learn how outcomes for older adults considering a stem cell transplant or CAR T-cell therapy can be optimized with programs that address their unique medical and psychosocial needs.
This is a recording of the webinar, Being a Caregiver: CAR T-Cell Therapy, that aired on February 1, 2023.
CAR T-cell therapy is a new approach to treating certain types of lymphoma, multiple myeloma and acute lymphoblastic leukemia that have not responded to two prior types of treatment.
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
CAR T-cell and other new drugs are expanding treatment options for patients with myeloma.
Learn how new cellular therapies, like CAR T-Cell therapy, can help patients with certain blood disorders.
¿Qué es la terapia con el receptor de antígeno quimérico (CAR-T)? ¿Quién es candidato para la terapia CAR-T?